| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |